Biden administration advancing $680 million arms sale to Israel, source says
Adds details about package, background
By Humeyra Pamuk
WASHINGTON, Nov 27 (Reuters) -The Biden administration is pushing ahead with a $680 million arms sales package to Israel, a U.S. official familiar with the plan said on Wednesday, even as a U.S.-brokered ceasefire in Lebanon between Israel and Hezbollah has come into effect.
The package, which was first reported by the Financial Times, includes thousands of joint direct attack munition kits (JDAM) and hundreds of small-diameter bombs, according to the official, speaking on condition of anonymity.
The news comes less than a day after the ceasefire agreement ended the deadliest confrontation in years between Israel and the Iran-backed militant group Hezbollah, but Israel is still fighting its other arch foe, the Palestinian militant group Hamas in the Gaza Strip.
However, the package has been in the works for several months. It was first previewed to the congressional committees in September then submitted for review in October, the official said.
The package follows a $20 billion sale in August of fighter jets and other military equipment to Israel.
Reuters reported in June that Washington, Israel's biggest ally and weapons supplier, has sent Israel more than 10,000 highly destructive 2,000-pound bombs and thousands of Hellfire missiles since the start of the Gaza war in October 2023.
The conversations about the latest arms package had been going on even as a group of progressive U.S. senators including Bernie Sanders introduced resolutions to block the sale of some U.S. weapons to Israel over concerns about the human rights catastrophe faced by Palestinians in Gaza.
The legislation was shot down in the Senate.
Biden, whose term ends in January, has strongly backed Israel since Hamas-led gunmen attacked in October 2023, killing 1,200 people and taking more than 250 hostages, according to Israeli tallies.
Most of Gaza's population of 2.3 million people has been displaced and the enclave is at risk of famine, more than a year into Israel's war against Hamas in the Palestinian enclave. Gaza health officials say more than 43,922 Palestinians have been killed in Israel's offensive.
Reporting by Humeyra Pamuk; Editing by Daniel Wallis
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
